Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 14, 2022

BUY
$11.32 - $16.63 $2.28 Million - $3.35 Million
201,601 New
201,601 $2.3 Million
Q3 2021

Nov 05, 2021

SELL
$11.32 - $16.63 $595,658 - $875,070
-52,620 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$15.16 - $18.97 $797,719 - $998,201
52,620 New
52,620 $842,000
Q2 2021

Aug 10, 2021

SELL
$15.16 - $18.97 $3.72 Million - $4.65 Million
-245,226 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$13.12 - $20.9 $3.22 Million - $5.13 Million
245,226 New
245,226 $4.38 Million
Q1 2021

May 07, 2021

SELL
$13.12 - $20.9 $3.21 Million - $5.12 Million
-244,976 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$9.12 - $14.49 $2.23 Million - $3.55 Million
244,976 New
244,976 $3.31 Million
Q4 2020

Feb 10, 2021

SELL
$9.12 - $14.49 $3.12 Million - $4.95 Million
-341,722 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$10.46 - $14.46 $3.57 Million - $4.94 Million
341,722 New
341,722 $4.02 Million
Q3 2020

Nov 10, 2020

SELL
$10.46 - $14.46 $4.18 Million - $5.78 Million
-399,753 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$12.0 - $16.13 $4.8 Million - $6.45 Million
399,753 New
399,753 $5.9 Million
Q2 2020

Aug 07, 2020

SELL
$12.0 - $16.13 $5.04 Million - $6.78 Million
-420,188 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$11.84 - $25.52 $4.98 Million - $10.7 Million
420,188 New
420,188 $5.67 Million
Q1 2020

May 08, 2020

SELL
$11.84 - $25.52 $4.98 Million - $10.7 Million
-420,188 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$17.72 - $25.1 $7.45 Million - $10.5 Million
420,188 New
420,188 $10.2 Million
Q4 2019

Feb 12, 2020

SELL
$17.72 - $25.1 $7.45 Million - $10.5 Million
-420,188 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$18.41 - $28.0 $7.74 Million - $11.8 Million
420,188 New
420,188 $8.08 Million
Q3 2019

Nov 08, 2019

SELL
$18.41 - $28.0 $7.18 Million - $10.9 Million
-389,821 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$28.97 - $48.21 $11.3 Million - $18.8 Million
389,821 New
389,821 $11.5 Million
Q2 2019

Aug 09, 2019

SELL
$28.97 - $48.21 $10.1 Million - $16.7 Million
-347,056 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$36.32 - $49.25 $1.72 Million - $2.34 Million
47,463 Added 15.84%
347,056 $16.5 Million
Q4 2018

Mar 04, 2019

BUY
$33.0 - $60.04 $9.89 Million - $18 Million
299,593 New
299,593 $10.8 Million
Q4 2018

Feb 08, 2019

SELL
$33.0 - $60.04 $9.89 Million - $18 Million
-299,593 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$56.15 - $73.9 $16.8 Million - $22.1 Million
299,593 New
299,593 $18.4 Million
Q3 2018

Nov 09, 2018

SELL
$56.15 - $73.9 $16.8 Million - $22.1 Million
-299,593 Closed
0 $0
Q2 2018

Aug 12, 2019

BUY
$47.85 - $70.45 $14.3 Million - $21.1 Million
299,593 New
299,593 $20.2 Million
Q2 2018

Jul 23, 2018

SELL
$47.85 - $70.45 $14.3 Million - $21.1 Million
-299,593 Closed
0 $0
Q1 2018

May 15, 2019

BUY
$51.15 - $61.0 $15.3 Million - $18.3 Million
299,593 New
299,593 $16.3 Million
Q1 2018

May 09, 2018

SELL
$51.15 - $61.0 $13.2 Million - $15.7 Million
-257,834 Closed
0 $0
Q4 2017

Mar 05, 2018

BUY
$50.85 - $65.1 $13.1 Million - $16.8 Million
257,834 New
257,834 $15.4 Million
Q4 2017

Feb 09, 2018

SELL
$50.85 - $65.1 $13.1 Million - $16.8 Million
-257,834 Closed
0 $0
Q3 2017

Nov 13, 2018

BUY
$48.6 - $60.1 $12.5 Million - $15.5 Million
257,834
257,834 $12.5 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.